NDC product
INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION · Takeda Pharmaceutical Company LTD
NDC 11532-1455 · Takeda Pharmaceutical Company LTD
Key facts
| Product NDC | 11532-1455 |
|---|---|
| Nonproprietary name | leuprolide acetate |
| Substances | LEUPROLIDE ACETATE |
| Dosage form | INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION |
| Labeler | Takeda Pharmaceutical Company LTD |
| Product type | DRUG FOR FURTHER PROCESSING |
| Marketing category | DRUG FOR FURTHER PROCESSING |
| Marketing start | Jun 17, 2011 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: